Rank 13 • Biotech & Discovery
Recursion
Operates an AI-enabled drug discovery platform mapping biological interactions to develop novel therapeutics.
Visit website- Signal Score
- 92.2
- Total raised
- $665M
- Stage
- Public
- Founded
- 2013
- Headquarters
- Salt Lake City, USA
- Region
- North America
Their signal
As a publicly traded pioneer in digital biology, Recursion's industrialized approach to scaling laboratory experiments alongside computational models makes it a flagship case study for artificial intelligence in medicine.
Signal Score 92.2editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Biotech & Discovery
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.